Sabra Healthcare REIT, Inc. $SBRA Shares Acquired by Bank of New York Mellon Corp

Bank of New York Mellon Corp lifted its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 1.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,175,058 shares of the real estate investment trust’s stock after purchasing an additional 60,843 shares during the quarter. Bank of New York Mellon Corp owned about 1.75% of Sabra Healthcare REIT worth $76,988,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Bank of Montreal Can raised its stake in Sabra Healthcare REIT by 244.1% in the second quarter. Bank of Montreal Can now owns 2,575,969 shares of the real estate investment trust’s stock valued at $47,501,000 after buying an additional 1,827,361 shares during the last quarter. State of Michigan Retirement System increased its holdings in shares of Sabra Healthcare REIT by 1.1% during the second quarter. State of Michigan Retirement System now owns 57,249 shares of the real estate investment trust’s stock valued at $1,056,000 after acquiring an additional 600 shares in the last quarter. Presima Securities ULC increased its holdings in shares of Sabra Healthcare REIT by 6.7% during the second quarter. Presima Securities ULC now owns 1,060,612 shares of the real estate investment trust’s stock valued at $19,558,000 after acquiring an additional 66,924 shares in the last quarter. Atria Investments Inc raised its position in shares of Sabra Healthcare REIT by 16.4% in the 2nd quarter. Atria Investments Inc now owns 38,117 shares of the real estate investment trust’s stock valued at $703,000 after purchasing an additional 5,375 shares during the last quarter. Finally, Retirement Systems of Alabama boosted its stake in Sabra Healthcare REIT by 18.6% in the 2nd quarter. Retirement Systems of Alabama now owns 1,170,912 shares of the real estate investment trust’s stock worth $21,592,000 after purchasing an additional 183,257 shares in the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Trading Up 0.2%

Shares of Sabra Healthcare REIT stock opened at $18.88 on Friday. The stock has a market cap of $4.53 billion, a PE ratio of 24.84, a price-to-earnings-growth ratio of 1.10 and a beta of 0.84. The firm has a fifty day moving average price of $18.40 and a 200 day moving average price of $18.26. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.01. The company had revenue of $190.04 million for the quarter, compared to the consensus estimate of $193.44 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period last year, the firm earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 28th. Investors of record on Monday, November 17th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.4%. The ex-dividend date is Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 157.89%.

Analysts Set New Price Targets

Several research firms have weighed in on SBRA. Weiss Ratings reissued a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, October 8th. Wells Fargo & Company dropped their price objective on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating on the stock in a report on Tuesday, October 21st. BMO Capital Markets upped their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a “market perform” rating in a research report on Monday, August 25th. JMP Securities raised their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research note on Wednesday, August 6th. Finally, National Bankshares set a $22.00 price target on Sabra Healthcare REIT in a research note on Friday, October 17th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $20.75.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.